Lack of evidence for post-vaccine onset of autoimmune/lymphoproliferative disorders, during a nine-month follow-up in multiply vaccinated Italian military personnel

Clin Immunol. 2017 Aug:181:60-66. doi: 10.1016/j.clim.2017.06.001. Epub 2017 Jun 15.

Abstract

Anecdotal case reports, amplified by mass media and internet-based opinion groups, have recently indicated vaccinations as possibly responsible for autoimmunity/lymphoproliferation development. Multiply vaccinated Italian military personnel (group 1, operating in Italy, group 2, operating in Lebanon) were followed-up for nine months to monitor possible post-vaccine autoimmunity/lymphoproliferation onset. No serious adverse event was noticed in both groups. Multivariate analysis of intergroup differences only showed a significant association between lymphocyte increase and tetanus/diphtheria vaccine administration. A significant post-vaccine decrease in autoantibody positivity was observed. Autoantibodies were also studied by microarray analysis of self-proteins in subjects exposed to ≥4 concurrent vaccinations, without observing significant difference among baseline and one and nine months post-vaccine. Moreover, HLA-A2 subjects have been analyzed for the possible CD8T-cell response to apoptotic self-epitopes, without observing significant difference between baseline and one month post-vaccine. Multiple vaccinations in young adults are safe and not associated to autoimmunity/lymphoproliferation onset during a nine-month-long follow-up.

Keywords: Apoptotic self-epitopes; Autoimmunity; Lymphoproliferation; Microarray analysis; Military personnel; Vaccinations.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Antibodies, Antineutrophil Cytoplasmic / immunology
  • Antibodies, Antinuclear / immunology
  • Antibodies, Antiphospholipid / immunology
  • Autoantibodies / immunology
  • Autoimmune Diseases / epidemiology*
  • Autoimmune Diseases / immunology
  • Blood Protein Electrophoresis
  • Chickenpox Vaccine / therapeutic use
  • Diphtheria-Tetanus Vaccine / therapeutic use
  • Female
  • Follow-Up Studies
  • Hepatitis A Vaccines / therapeutic use
  • Hepatitis B Vaccines / therapeutic use
  • Humans
  • Immunoglobulins / blood
  • Influenza Vaccines / therapeutic use
  • Italy / epidemiology
  • Lymphoproliferative Disorders / epidemiology*
  • Lymphoproliferative Disorders / immunology
  • Male
  • Measles-Mumps-Rubella Vaccine / therapeutic use
  • Meningococcal Vaccines / therapeutic use
  • Military Personnel / statistics & numerical data*
  • Poliovirus Vaccine, Inactivated / therapeutic use
  • Prospective Studies
  • Rheumatoid Factor / immunology
  • Risk Factors
  • Typhoid-Paratyphoid Vaccines / therapeutic use
  • Vaccines / therapeutic use*
  • Young Adult

Substances

  • Antibodies, Antineutrophil Cytoplasmic
  • Antibodies, Antinuclear
  • Antibodies, Antiphospholipid
  • Autoantibodies
  • Chickenpox Vaccine
  • Diphtheria-Tetanus Vaccine
  • Hepatitis A Vaccines
  • Hepatitis B Vaccines
  • Immunoglobulins
  • Influenza Vaccines
  • Measles-Mumps-Rubella Vaccine
  • Meningococcal Vaccines
  • Poliovirus Vaccine, Inactivated
  • Typhoid-Paratyphoid Vaccines
  • Vaccines
  • anti-extractable nuclear antigen antibodies
  • Rheumatoid Factor